Remedies for inflammatory bowel diseases
AssigneeJapan Tobacco Inc.
InventorMamoru Watanabe
Life of this patent
Estimating the term…
Abstract
Antibodies against AILIM (also called ICOS and 8F4) were found to significantly suppress the onset of inflammatory bowel diseases (especially Crohn's disease and colitis (ulcerative colitis and such)), and exhibit a significant therapeutic effect against inflammatory bowel diseases.
Claims21
1-10. (canceled)
A method of suppressing or treating a disease that accompanies abnormal immunity of the intestinal tract in a subject, the method comprising administering to the subject an effective amount of a composition comprising (a) an antibody or a portion thereof that binds to human AILIM, and (b) a pharmaceutically acceptable carrier.
A method of suppressing or treating an inflammatory bowel disease in a subject, the method comprising administering to the subject an effective amount of a composition comprising (a) an antibody or a portion thereof that binds to human AILIM, and (b) a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.